Matrine Ameliorates Colorectal Cancer in Rats via Inhibition of HMGB1 Signaling and Downregulation of IL-6, TNF-α, and HMGB1.
Matrine Ameliorates Colorectal Cancer in Rats via Inhibition of HMGB1 Signaling and Downregulation of IL-6, TNF-α, and HMGB1.
复制标题
DOI:
10.1155/2018/5408324
复制
发表时间:
2018
影响因子:
4.1
通讯作者:
Zhao H
中科院分区:
文献类型:
--
作者:
Fan H;Jiang C;Zhong B;Sheng J;Chen T;Chen Q;Li J;Zhao H
Matrine may be protective against colorectal cancer (CRC), but how it may work is unclear. Thus, we explored the underlying mechanisms of matrine in CRC. Matrine-related proteins and CRC-related genes and therapeutic targets of matrine in CRC were predicted using a network pharmacology approach. Five targets, including interleukin 6 (IL-6), the 26S proteasome, tumor necrosis factor alpha (TNF-α), transforming growth factor beta 1 (TGF-β1) and p53, and corresponding high-mobility group box 1 (HMGB1) signaling and T helper cell differentiation were thought to be associated with matrine's mechanism. Expression of predicted serum targets were verified in a 1,2-dimethylhydrazine dihydrochloride-induced CRC model rats that were treated with matrine (ip) for 18 weeks. Data show that matrine suppressed CRC growth and decreased previously elevated expression of IL-6, TNF-α, p53, and HMGB1. Matrine may have had a therapeutic effect on CRC via inhibition of HMGB1 signaling, and this occurred through downregulation of IL-6, TNF-α, and HMGB1.
登录
查看更多内容
DOI:
10.5114/wo.2016.65605
发表时间:
2016
期刊:
Contemporary oncology (Poznan, Poland)
影响因子:
--
作者:
Stanilov NS;Miteva L;Cirovski G;Stanilova SA
通讯作者:
Stanilova SA
影响因子:
5.7
作者:
Klune, John R.;Dhupar, Rajeev;Cardinal, Jon;Billiar, Timothy R.;Tsung, Allan
通讯作者:
Tsung, Allan
影响因子:
20.1
作者:
Chan SY;Loscalzo J
通讯作者:
Loscalzo J
影响因子:
168.9
作者:
Cunningham, David;Atkin, Wendy;Starling, Naureen
通讯作者:
Starling, Naureen
影响因子:
64.8
作者:
Liu, Yunhua;Zhang, Xinna;Lu, Xiongbin
通讯作者:
Lu, Xiongbin